Bank of America Global Research recently announced the official initiation of research coverage on biotechnology company Eikon Therapeutics (stock code: EIKN), and assigned an initial "Buy" rating.

老虎证券2026/03/02 12:13

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The institution has also set a target share price of $34, demonstrating a positive outlook on the company's future growth prospects. The initiation of coverage marks the recognition by major Wall Street institutions of Eikon Therapeutics' technological strength in the field of innovative drug development. Analysts pointed out in the report that the company's unique platform technology and R&D pipeline layout have laid a solid foundation for its long-term value enhancement.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alphabet has issued euro-denominated bonds for the second time this year, across seven tranches with maturities ranging from 2 to 19 years. Concerns over AI spending have widened credit spreads, and credit default swap contracts surged by 6.4 basis points in a single day to nearly 91 basis points, reaching a historic high.

智通财经•2026/11/02 08:46